Personal information

No personal information available

Activities

Collapse all

Employment (1)

University of Washington: Seattle, WA, US

Professor Emeritus (Pharmacy)
Employment
Source: Self-asserted source
Louis Garrison

Works (12)

A prospective model of the potential clinical and economic impact of cervical cancer screening supported by a mobile phone app

PLOS ONE
2025-01-31 | Journal article
DOI: 10.1371/journal.pone.0316001
Contributors: Fredrick Chite Asirwa; Edward Adekola Oladele; Brian W. Bresnahan; Faith Yego; Dana Duncan; James K. Karichu; Louis P. Garrison Jr.
Source: check_circle
Crossref

The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations

Future Oncology
2024-06-06 | Journal article
DOI: 10.2217/fon-2023-0514
Contributors: William Wong; Stacey Kowal; Tu My To; Achal Patel; David Veenstra; Louis Garrison; Meng Li
Source: check_circle
Crossref

A review of economic issues for gene‐targeted therapies: Value, affordability, and access

American Journal of Medical Genetics Part C: Seminars in Medical Genetics
2023-03 | Journal article
DOI: 10.1002/ajmg.c.32037
Contributors: Louis P. Garrison, Jr; Andrew W. Lo; Richard S. Finkel; Patricia A. Deverka
Source: check_circle
Crossref

Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trial

Journal of Medical Economics
2022-12-31 | Journal article
DOI: 10.1080/13696998.2021.2011301
Contributors: Jipan Xie; Yan Wang; Yaping Xu; Jennifer T. Fine; Jenny Lam; Louis P. Garrison
Source: check_circle
Crossref

Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung Cancer

PharmacoEconomics
2022-06 | Journal article
DOI: 10.1007/s40273-022-01147-5
Contributors: Woojung Lee; William B. Wong; Stacey Kowal; Louis P. Garrison, Jr.; David L. Veenstra; Meng Li
Source: check_circle
Crossref

Assessing the potential cost-effectiveness of centralized vs point-of-care testing for hepatitis C virus in Pakistan: a model-based comparison

2022-04-03 | Preprint
DOI: 10.1101/2022.03.31.22273228
Contributors: Joseph B. Babigumira; James K. Karichu; Samantha Clark; Mindy M. Cheng; Louis P. Garrison, Jr.; Maciej B. Maniecki; Saeed S. Hamid
Source: check_circle
Crossref

Concern about addiction is associated with lower quality of life in patients with osteoarthritis: an exploratory, real-world data analysis

Quality of Life Research
2022-01 | Journal article
DOI: 10.1007/s11136-021-02907-0
Contributors: Louis P. Garrison; Patricia Schepman; Andrew G. Bushmakin; Rebecca L. Robinson; Leslie Tive; Jerry Hall; Mendwas Dzingina; James Jackson; Mia Berry; Joseph C. Cappelleri et al.
Source: check_circle
Crossref

Projecting the Long-term Clinical Value of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy in the United States: An Assessment of Net Health Benefit

Clinical Therapeutics
2022-01 | Journal article
DOI: 10.1016/j.clinthera.2021.11.006
Contributors: Nihar Desai; Jipan Xie; Yan Wang; Megan B. Sutton; John Whang; Jennifer T. Fine; Louis P. Garrison, Jr
Source: check_circle
Crossref

Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting?

Cost Effectiveness and Resource Allocation
2021-12 | Journal article
DOI: 10.1186/s12962-021-00266-8
Contributors: Bernarda Zamora; Louis P. Garrison; Aig Unuigbe; Adrian Towse
Source: check_circle
Crossref

The challenge of value-based pricing in combination therapy: the case of trastuzumab and pertuzumab in HER2+ metastatic breast cancer

Expert Review of Pharmacoeconomics & Outcomes Research
2021-05-04 | Journal article
DOI: 10.1080/14737167.2021.1896968
Contributors: Boshen Jiao; Louis P. Garrison, , Jr.
Source: check_circle
Crossref

Reconciling ACEA and MCDA: Is There a Way Forward for  Measuring Cost-Effectiveness in the U.S. Healthcare Setting?

2020-10-27 | Preprint
DOI: 10.21203/rs.3.rs-96278/v1
Contributors: Bernarda Zamora; Louis Garrison; Aig Unuigbe; Adrian Towse
Source: check_circle
Crossref

Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia A

Journal of Medical Economics
2020-05-03 | Journal article
DOI: 10.1080/13696998.2020.1721508
Contributors: Keziah Cook; Shaun P. Forbes; Kelly Adamski; Janice J. Ma; Anita Chawla; Louis P. Garrison, Jr.
Source: check_circle
Crossref
How many people are using ORCID?